Suppr超能文献

全基因组关联研究鉴定出四个早发性精神分裂症的位点。

Genome wide association study identifies four loci for early onset schizophrenia.

机构信息

Henan Mental Hospital, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453002, China.

Henan Key Lab of Biological Psychiatry, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan, Xinxiang Medical University, Xinxiang, Henan, 453002, China.

出版信息

Transl Psychiatry. 2021 Apr 27;11(1):248. doi: 10.1038/s41398-021-01360-4.

Abstract

Early onset schizophrenia (EOS, defined as first onset of schizophrenia before age 18) is a rare form of schizophrenia (SCZ). Though genome-wide association studies (GWASs) have identified multiple risk variants for SCZ, most of the cases included in these GWASs were not stratified according to their first age at onset. To date, the genetic architecture of EOS remains largely unknown. To identify the risk variants and to uncover the genetic basis of EOS, we conducted a two-stage GWAS of EOS in populations of Han Chinese ancestry in this study. We first performed a GWAS using 1,256 EOS cases and 2,661 healthy controls (referred as discovery stage). The genetic variants with a P < 1.0 × 10 in discovery stage were replicated in an independent sample (903 EOS cases and 3,900 controls). We identified four genome-wide significant risk loci for EOS in the combined samples (2,159 EOS cases and 6,561 controls), including 1p36.22 (rs1801133, P = 4.03 × 10), 1p31.1 (rs1281571, P = 4.14 × 10), 3p21.31 (rs7626288, P = 1.57 × 10), and 9q33.3 (rs592927, P = 4.01 × 10). Polygenic risk scoring (PRS) analysis revealed substantial genetic overlap between EOS and SCZ. These discoveries shed light on the genetic basis of EOS. Further functional characterization of the identified risk variants and genes will help provide potential targets for therapeutics and diagnostics.

摘要

早发性精神分裂症(EOS,定义为 18 岁之前首次出现精神分裂症)是一种罕见的精神分裂症(SCZ)形式。尽管全基因组关联研究(GWAS)已经确定了多个 SCZ 的风险变异,但这些 GWAS 中包含的大多数病例并未根据其首次发病年龄进行分层。迄今为止,EOS 的遗传结构在很大程度上仍然未知。为了确定风险变异并揭示 EOS 的遗传基础,我们在本研究中对汉族人群进行了两阶段 EOS 的 GWAS。我们首先使用 1,256 例 EOS 病例和 2,661 例健康对照进行 GWAS(称为发现阶段)。在发现阶段,P 值<1.0×10 的遗传变异在独立样本中进行了复制(903 例 EOS 病例和 3,900 例对照)。我们在合并样本中鉴定出四个与 EOS 相关的全基因组显著风险位点(2,159 例 EOS 病例和 6,561 例对照),包括 1p36.22(rs1801133,P=4.03×10)、1p31.1(rs1281571,P=4.14×10)、3p21.31(rs7626288,P=1.57×10)和 9q33.3(rs592927,P=4.01×10)。多基因风险评分(PRS)分析显示 EOS 和 SCZ 之间存在显著的遗传重叠。这些发现为 EOS 的遗传基础提供了线索。对鉴定出的风险变异和基因的进一步功能特征分析将有助于为治疗和诊断提供潜在的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/8079394/36e7b28ab0f9/41398_2021_1360_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验